VA Office of Research and Development
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, VA Office of Research and Development sits in the top decile of US sponsors by registered trial count (#11 of 15,751 sponsors by registered trial count).
VA Office of Research and Development: 1,668 sponsored US clinical trials, 291 recruiting.
VA Office of Research and Development sponsors 1,668 registered US clinical trials on ClinicalTrials.gov, 291 of them currently recruiting, and 1,108 completed. 124 of these trials are in Phase 3-4 (later-stage) and 236 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is PTSD, with 28 trials.
Top-decile sponsor footprint
VA Office of Research and Development ranks in the top decile of sponsors by registered trial count (#11 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
1,668 total, page 32 of 34
Evidence Synthesis: Hypertension Medication Adherence & Intensification
NCT00682968
Telerehabilitation for OIF/OEF Returnees With Combat-Related Traumatic Brain Injury
NCT00676182
Behavioral and Neuroimaging Changes After Cognitive Rehab in Traumatic Brain Injuries (TBI) and Mild Cognitive Impairment (MCI)
NCT00714571
The Efficacy of Familiar Voice Stimulation During Coma Recovery
NCT00557076
Understanding Different Parameters in Locomotor Training (a Type of Walking Training) for Person After a Stroke
NCT00712179
Proteolytic Enzyme Induction Within the Human Myocardial Interstitium
NCT00744211
Brain Injury Outcomes (BIO) Study
NCT00724607
Pharmacist-led Group Medical Visits to Help With Diabetes Management
NCT00554671
Exercise to Reduce Obesity in Spinal Cord Injury
NCT00270855
Improving Medical Training for the Care of Chronic Conditions
NCT00676208
Do Consumer Providers Enhance Recovery?
NCT00781079
PTSD Symptom Reduction by Propranolol Given After Trauma Memory Activation
NCT00645450
Telehealth Outreach for Chronic Back Pain
NCT00608530
The VA Diabetes Trial Follow-up Study (VADT-FS)
NCT00756613
Mechanisms of Upper-Extremity Motor Recovery in Post-stroke Hemiparesis
NCT00125658
Illness Management and Recovery for Veterans With Severe Mental Illness
NCT00515671
Exposure Therapy for Chronic PTSD: Efficacy and Mechanisms
NCT00475241
Statin Therapy Versus Placebo Prior to Prostatectomy
NCT00572468
Evaluation of Stepped Care for Chronic Pain in Iraq/Afghanistan Veterans (ESCAPE)
NCT00386243
An Intervention to Improve Function in Severe Cardiopulmonary Illness
NCT00467298
Can Simple and Inexpensive Techniques Enhance Patient Comfort
NCT00747084
Efficacy of Macrolide Immunomodulation in Severe Sepsis.
NCT00708799
Awareness of Deficit After Combat-related Brain Injury
NCT00478400
Depression and Congestive Heart Failure in Outpatients.
NCT00321269
Low-Dose Opiate Therapy for Discomfort in Dementia (L-DOT)
NCT00385684
Effects of Training on Central Auditory Function in Multiple Sclerosis
NCT01023074
Central Auditory Processing Disorders Associated With Blast Exposure
NCT00554801
Regional Anesthesia Military Battlefield Pain Outcomes Study
NCT00431847
PDA+: A Personal Digital Assistant for Obesity Treatment
NCT00371462
Senior Coordinated Referral Study
NCT00404118
Improving Basic and Social Cognition in Veterans With Schizophrenia
NCT00470106
Methylphenidate for Apathy in Alzheimer's Dementia: A Controlled Study
NCT00495820
MIND-ICU Study: Delirium and Dementia in Veterans Surviving ICU Care
NCT00400062
A Biochip for Rapid Diagnosis of Complicated Urinary Tract Infection
NCT00591240
Use of Telehealth In-home Messaging to Improve GI (Gastrointestinal) Endoscopy Completion Rates
NCT00310362
Implementing Effective, Collaborative Care for Schizophrenia (EQUIP-2)
NCT00137280
Patient and Provider Attitudes in the Healthcare Context
NCT00404027
The Effect of a Contingency Management Intervention on Substance Use
NCT00252512
Mechanistically-based Optimization of UV Radiation Therapy in Psoriasis
NCT00470392
Exercise and Inflammation in the Elderly
NCT00753363
Use of Subtle Vibration to Improve Walking Ability by Lower Limb Amputees
NCT00985881
Quality Improvement of Patient-Provider Communication For Colorectal Cancer Screening
NCT00324753
Cardiovascular Disease Study
NCT00857194
HIV Translating Initiatives for Depression Into Effective Solutions
NCT00304915
Financial Incentives to Translate ALLHAT Into Practice: A Randomized Trial
NCT00302718
Development of NIC5-15 in the Treatment of Alzheimer's Disease
NCT00470418
VISN Collaborative for Improving Hypertension Management With ATHENA-HTN
NCT00374452
5-Alpha Reductase and Anabolic Effects of Testosterone
NCT00475501
Salsalate Therapy to Reduce Insulin Resistance and Cardiovascular Risk
NCT00330733
Effects of PPAR Ligands on Ectopic Fat Accumulation and Inflammation
NCT00470262
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 89 |
| Phase 2 | 147 |
| Phase 3 | 55 |
| Phase 4 | 69 |
Therapeutic Areas
What is open in the VA Office of Research and Development pipeline
291 recruiting of 1,668 indexed (17% open); 1,108 completed (66%).
Phase mix: 124 late (III/IV) vs 236 early (I/II) (early-phase heavy).
Top condition: PTSD (28 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.